Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111840802 | 11184080 | 2 | F | 20150511 | 20150531 | 20150612 | 20160720 | EXP | IT-MINISAL02-309560 | IT-MYLANLABS-2015M1017634 | MYLAN | 0.00 | Y | 0.00000 | 20160720 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111840802 | 11184080 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 266 MG, CYCLE | 91540 | 266 | MG | ||||||||
| 111840802 | 11184080 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 470 MG, CYCLE | 0 | 470 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111840802 | 11184080 | 1 | Endometrial cancer |
| 111840802 | 11184080 | 2 | Endometrial cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111840802 | 11184080 | Asthenia | |
| 111840802 | 11184080 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111840802 | 11184080 | 1 | 20150310 | 0 | ||
| 111840802 | 11184080 | 2 | 20150310 | 0 |